Nanostart-holding MagForce Nanotechnologies Announces Capital Increase from Authorized Capital

FRANKFURT, Germany & BERLIN--(BUSINESS WIRE)--The Management Board of Nanostart (OTCQX:NASRY) - holding MagForce AG (XETRA:MF6), a leading medical technology company focusing on nanomedicine in oncology, and its Supervisory Board yesterday approved an increase in the companys share capital from EUR 4,127,041.00 up to EUR 4,952,449.00 through the partial utilization of its existing authorized capital...